United States · FDA National Drug Code directory
COMPOUND OYSTER PEPTIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 85631-004_3b778dc1-d1ad-1415-e063-6394a90aeb39
- Product NDC
- 85631-004
- Form
- CAPSULE
- Composition / generic term
- COMPOUND OYSTER PEPTIDE
- Labeler
- Bispit Canada Ltd.
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start / end (source format)
- 20250803
- Source listing expiry
- 20261231
Source-listed ingredients
- LYCIUM CHINENSE FRUIT — 270 mg/1.2g
- ASIAN GINSENG — 180 mg/1.2g
- LICORICE — 24 mg/1.2g
- POLYGONATUM SIBIRICUM WHOLE — 90 mg/1.2g
- PHYLLOLOBIUM CHINENSE SEED — 72 mg/1.2g
- RIBOFLAVIN — .24 mg/1.2g
- ZINC LACTATE — 5.16 mg/1.2g
- TAURINE — 30 mg/1.2g
- THIAMINE — .6 mg/1.2g
- CORNUS OFFICINALIS WHOLE — 180 mg/1.2g
- SEA CUCUMBER, UNSPECIFIED — 120 mg/1.2g
- DIOSCOREA CAYENENSIS TUBER — 96 mg/1.2g
- WHITE MULBERRY — 72 mg/1.2g
- OYSTER, UNSPECIFIED — 12 mg/1.2g
These values do not establish equivalence or a dose recommendation.
Packages
- 60 CAPSULE in 1 BOTTLE (85631-004-01) / 1.2 g in 1 CAPSULE · 85631-004-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →